Literature DB >> 10579829

Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation.

M Jung1, G Brosch, D Kölle, H Scherf, C Gerhäuser, P Loidl.   

Abstract

Inhibitors of histone deacetylase (HD) bear great potential as new drugs due to their ability to modulate transcription and to induce apoptosis or differentiation in cancer cells. We have described previously analogues of the complex natural HD inhibitors trapoxin B and trichostatin A with activities in the submicromolar range. Here we report structure-activity relationship analyses of further analogues of trichostatin A with respect to in vitro inhibition of maize HD-2 and their ability to induce terminal cell differentiation in Friend leukemic cells. This is the first report that shows the correlation between HD inhibitory activity and action on cancer cells on a larger series of similar compounds. Only the compounds that inhibit HD induce differentiation and/or exert antiproliferative activities in cell culture. Our studies support the use of in vitro systems as screening tools and provide structure-activity relationships that merit further investigation of this interesting target.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579829     DOI: 10.1021/jm991091h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

1.  Induction of human gamma globin gene expression by histone deacetylase inhibitors.

Authors:  Hua Cao; George Stamatoyannopoulos; Manfred Jung
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113

2.  Histone Deacetylase Inhibitor M344 Inhibits Cell Proliferation and Induces Apoptosis in Human THP-1 Leukemia Cells.

Authors:  Xiaohua Li; Ben D Chen
Journal:  Am J Biomed Sci       Date:  2009-06-09

3.  p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation.

Authors:  Vikram Devgan; Cristina Mammucari; Sarah E Millar; Cathrin Brisken; G Paolo Dotto
Journal:  Genes Dev       Date:  2005-06-15       Impact factor: 11.361

4.  The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.

Authors:  Markus Riessland; Lars Brichta; Eric Hahnen; Brunhilde Wirth
Journal:  Hum Genet       Date:  2006-05-25       Impact factor: 4.132

5.  Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors.

Authors:  Joanna Fraczek; Sarah Deleu; Aneta Lukaszuk; Tatyana Doktorova; Dirk Tourwé; Albert Geerts; Tamara Vanhaecke; Karin Vanderkerken; Vera Rogiers
Journal:  Invest New Drugs       Date:  2008-09-30       Impact factor: 3.850

6.  Development of a fluorescence polarization based assay for histone deacetylase ligand discovery.

Authors:  Ralph Mazitschek; Vishal Patel; Dyann F Wirth; Jon Clardy
Journal:  Bioorg Med Chem Lett       Date:  2008-04-07       Impact factor: 2.823

7.  HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.

Authors:  Xiaohua Li; Alexander Kaplun; Fulvio Lonardo; Elisabeth Heath; Fazlul H Sarkar; Jonathan Irish; Wael Sakr; Shijie Sheng
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

8.  Inhibition of NF-kappaB activation by the histone deacetylase inhibitor 4-Me2N-BAVAH induces an early G1 cell cycle arrest in primary hepatocytes.

Authors:  P Papeleu; A Wullaert; G Elaut; T Henkens; M Vinken; G Laus; D Tourwé; R Beyaert; V Rogiers; T Vanhaecke
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

9.  In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors.

Authors:  Roula Konsoula; Mira Jung
Journal:  Int J Pharm       Date:  2008-05-13       Impact factor: 5.875

10.  Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer.

Authors:  Noriyuki Takai; Hisashi Narahara
Journal:  Obstet Gynecol Int       Date:  2010-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.